University of California San Francisco

Give to UCSF
Advanced
690 Results in the UCSF News Center
Type of Article
Areas of Focus
Date of Publication
Health And Science Topics
Campus Topics

Cell of origin for brain tumors may predict response to therapy

For patients with glioma, the most common primary brain tumor, new findings may explain why current therapies fail to eradicate the cancer. A UCSF-led team of scientists has identified for the first time that progenitor rather than neural stem cells underly a type of glioma called oligodendroglioma.

Placeholder image

Genetics Research Accelerates Pace of Knowledge Gains

New technologies and techniques continue to accelerate the pace of discovery in human genetics research, a fact made clear by scientists who spoke about their searches for important mutations, gene variants and answers to basic biological questions at the UCSF Institute for Human Genetics’ fifth-anniversary symposium on Oct. 28.

Placeholder image

UCSF leads Lancet series on malaria elimination

<em>The Lancet</em> launched a special series on malaria elimination Oct. 29, led by the Global Health Group (GHG), a part of UCSF Global Health Sciences. The series included work by 36 authors worldwide, with guidance and support provided by a GHG-convened global advisory group of malaria experts, known as the Malaria Elimination Group.

Placeholder image

UCSF Launches Social Media Fundraising Campaign for Benioff Children's Hospital

The UCSF Challenge for the Children, a collaboration with the online fundraising platform Causes.com, kicks off today (Oct. 26, 2010) as part of the groundbreaking festivities for the new UCSF Medical Center at Mission Bay, site of the future children&#8217;s hospital as well as women&#8217;s and cancer hospitals.

Placeholder image

UCSF diabetes symposium marks decade of research advances

Diabetes research is on the cusp of new advances in treatment options and in understanding the underlying causes of both type 1 and type 2 diabetes. Among those are potential treatments using stem cells to regenerate a patient&#8217;s ability to produce insulin, as well as upcoming clinical trials of a vaccine that potentially could prevent type 1 diabetes.

Placeholder image